Discover the detailed record of transactions filed by 叶兰, Director. Insider active across 1 companies, notably 派林生物. In total, 46 disclosures have been recorded. The latest transaction was disclosed on 25 April 2025 — Purchase. Regulator: AMF. The full history is free.
Declarations 46 total
80,000 shares
SSE:173000009835496400 · 27 Nov 2025
30,000 shares
SSE:173000009827576740 · 24 Nov 2025
30,000 shares
SSE:173000009783837660 · 17 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 8,000 shares
SSE:173000009783837730 · 17 Nov 2025
10,000 shares
SSE:173000009775577400 · 13 Nov 2025
69,900 shares
SSE:173000009738442370 · 11 Nov 2025
20,000 shares
SSE:173000009726371520 · 10 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 20,000 shares
SSE:173000009717809440 · 6 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 10,000 shares
SSE:173000009717809470 · 6 Nov 2025
6,000 shares
SSE:173000009717809800 · 6 Nov 2025
50,000 shares
SSE:173000009712471970 · 5 Nov 2025
Executives ● Purchase派 派林生物 18 SZSE €19,584 7,500 shares
SZSE:173000008868500580 · 25 Apr 2025
Ideal exit: 20 Jan 2026 (T+270) Executives ● Purchase派 派林生物 22 SZSE €13,056 5,000 shares
SZSE:173000008868500400 · 25 Apr 2025
Ideal exit: 20 Jan 2026 (T+270) Executives ● Purchase派 派林生物 7 SZSE €542 200 shares
SZSE:173000008717793300 · 24 Feb 2025
Ideal exit: 21 Nov 2025 (T+270) Executives ● Purchase派 派林生物 7 SZSE €5,572 2,000 shares
SZSE:173000008552387420 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €4,321 1,500 shares
SZSE:173000008451201340 · 14 Jan 2025
Ideal exit: 11 Oct 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €2,185 800 shares
SZSE:173000008409120800 · 7 Jan 2025
Ideal exit: 4 Oct 2025 (T+270) Executives ● Purchase派 派林生物 11 SZSE €27,529 10,000 shares
SZSE:173000008405393340 · 6 Jan 2025
Ideal exit: 3 Oct 2025 (T+270) Executives ● Purchase派 派林生物 7 SZSE €5,506 2,000 shares
SZSE:173000008405393300 · 6 Jan 2025
Ideal exit: 3 Oct 2025 (T+270) Executives ● Purchase派 派林生物 11 SZSE €14,076 5,000 shares
SZSE:173000008396452540 · 2 Jan 2025
Ideal exit: 29 Sept 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €5,631 2,000 shares
SZSE:173000008396452580 · 2 Jan 2025
Ideal exit: 29 Sept 2025 (T+270) Executives ● Purchase尤 尤夫股份 11 SZSE 5,700 shares
SZSE:173000008264542800 · 14 Nov 2024
Ideal exit: 11 Aug 2025 (T+270) Executives ● Purchase尤 尤夫股份 7 SZSE 4,000 shares
SZSE:173000008138114020 · 30 Sept 2024
Ideal exit: 27 Jun 2025 (T+270) Executives ● Purchase尤 尤夫股份 7 SZSE 8,000 shares
SZSE:173000007882566600 · 25 Jul 2024
Ideal exit: 21 Apr 2025 (T+270) Executives ● Sale派 派林生物 7 SZSE 3,500,000 shares
SZSE:173000006682573300 · 26 Jun 2023
25 of 46 declarations
Load more (21 remaining) About 叶兰 Ye Lan is a director and executive at 派林生物, where she contributes to defining strategies and overseeing operations. With expertise in the biotechnology sector, she is involved in assessing the company's performance and implementing innovative solutions. Her commitment to regulatory compliance and ethics is essential to ensure the company's sustainability.